Home > Income Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Revenue

    Back to Income Statement
PIRAMAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹8,869 Cr₹9,151 Cr₹8,171 Cr₹7,082 Cr₹6,559 Cr

What is the latest Revenue of PIRAMAL PHARMA ?

The latest Revenue ratio of PIRAMAL PHARMA is ₹8,869 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹8,869 Cr
Mar2025₹9,151 Cr
Mar2024₹8,171 Cr
Mar2023₹7,082 Cr
Mar2022₹6,559 Cr

How is Revenue of PIRAMAL PHARMA Trending?

Years Revenue % Change
Mar2026 ₹8,869 Cr
-3.08
Mar2025 ₹9,151 Cr
11.99
Mar2024 ₹8,171 Cr
15.39
Mar2023 ₹7,082 Cr
7.97
Mar2022 ₹6,559 Cr -

Compare Revenue of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹28,003.9 Cr 1% 22.3% 10.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹464,271.0 Cr -0.5% -0.3% 18.9% Stock Analytics
DIVIS LABORATORIES ₹226,843.0 Cr 3.1% 18.9% 33.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,000.0 Cr -1.5% -1.6% 35.6% Stock Analytics
CIPLA ₹118,072.0 Cr -0.9% 1.6% -2.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,073.0 Cr 2% -3.8% -0.7% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

1%

22.3%

10.6%

SENSEX

-0.8%

0.5%

-3.8%


You may also like the below Video Courses